synthesized a novel compound consisting of (ZnDPA)6‐DP‐15K designated as ExoBlock, which is a multivalent PS binder that substantially inhibits the immunosuppressive activity of exosomes, leading to an increase in both the quantity and functionality of CD4+ and CD8+ T cells in ovarian tumors and melanoma. Here, CD8A is linked to melanoma.